Study on the bias-dependent effects of proton-induced damage in CdZnTe radiation detectors using ion beam induced charge microscopy.

Yaxu Gu,W. Jie,Caicai Rong,Lingyan Xu,Yadong Xu,H. Lv,H. Shen,G. Du,Na Guo,Rongrong Guo,G. Zha,Tao Wang,Shouzhi Xi

DOI: https://doi.org/10.1016/j.micron.2016.06.003

IF: 2.381

2016-09-01

Micron

Abstract:

What problem does this paper attempt to address?

Short-Chain Fatty Acids Stimulate Glucagon-Like Peptide-1 Secretion via the G-Protein–Coupled Receptor FFAR2

Gwen Tolhurst,Helen Heffron,Yu Shan Lam,Helen E. Parker,Abdella M. Habib,Eleftheria Diakogiannaki,Jennifer Cameron,Johannes Grosse,Frank Reimann,Fiona M. Gribble

DOI: https://doi.org/10.2337/db11-1019

IF: 7.7

2012-01-17

Diabetes

Abstract:Interest in how the gut microbiome can influence the metabolic state of the host has recently heightened. One postulated link is bacterial fermentation of “indigestible” prebiotics to short-chain fatty acids (SCFAs), which in turn modulate the release of gut hormones controlling insulin release and appetite. We show here that SCFAs trigger secretion of the incretin hormone glucagon-like peptide (GLP)-1 from mixed colonic cultures in vitro. Quantitative PCR revealed enriched expression of the SCFA receptors ffar2 (grp43) and ffar3 (gpr41) in GLP-1–secreting L cells, and consistent with the reported coupling of GPR43 to Gq signaling pathways, SCFAs raised cytosolic Ca2+ in L cells in primary culture. Mice lacking ffar2 or ffar3 exhibited reduced SCFA-triggered GLP-1 secretion in vitro and in vivo and a parallel impairment of glucose tolerance. These results highlight SCFAs and their receptors as potential targets for the treatment of diabetes.

endocrinology & metabolism
Food and feeding habit of taiwan mauxia shrimp Acetes intermedius in the coastal waters of Southwestern Taiwan

Wann-Duen Chiou,J. Hwang,Lei Cheng,C. Chen

DOI: https://doi.org/10.1111/j.1444-2906.2005.00988.x

2005-04-01

Fisheries Science

Abstract:The stomach contents and feeding habits of the Taiwan mauxia shrimp Acetes intermedius were examined based on 420 specimens collected in the costal waters of south-western Taiwan. Two 24-h periodic samplings of specimens were completed to describe the diel feeding periodicity of this species. Phytoplankton was the main food for the Taiwan mauxia shrimp, and the dinoflagellates was the most important food. They also fed on zooplankton and amorphous materials. Their diet changed with the seasons. The feeding activity of this species mainly occurred at night. The results obtained in this study supported the hypothesis that A. intermedius performs a nocturnal vertical migration to avoid predators and to allow for safe feeding.
[THE AIR TRAVELER WITH RESPECT TO THE HYGIENIST].

R. Hugonot

1963-10-01

Abstract:
Regulation of peptide-YY synthesis and secretion in fetal rat intestinal cultures

P L Brubaker,D J Drucker,S L Asa,G R Greenberg

DOI: https://doi.org/10.1210/endo-129-6-3351

IF: 5.051

Endocrinology

Abstract:The regulation of intestinal peptide-YY (PYY) synthesis and secretion has not been well studied. We have used fetal rat intestinal cells in culture to examine the intra- and extracellular factors controlling the production of PYY. Immunohistochemical analysis demonstrated a distinct population of cells containing immunoreactive PYY (IR-PYY). When examined by HPLC, the IR-PYY stored and secreted by fetal rat intestinal cell cultures eluted as a single moiety with the same elution time as synthetic rat PYY. Pro-PYY mRNA transcript levels and secretion of IR-PYY into the cell medium were increased by activation of protein kinase-A with either a long-acting cAMP analog or forskolin. In contrast, IR-PYY secretion only was stimulated in a synergistic fashion through calcium- and protein kinase-C-dependent pathways (stimulated with A23187 and phorbol myristate acetate, respectively). The intestinal endocrine peptide, gastric inhibitory peptide, and the neurocrine peptide, gastrin-releasing peptide, were found to stimulate IR-PYY secretion in a dose-dependent fashion, with significant effects observed at concentrations as low as 10(-8) and 10(-12) M, respectively (P less than 0.05-0.001). Cholecystokinin and vasoactive intestinal peptide were without effect on IR-PYY secretion at doses of 10(-12)-10(-6) M. The fatty acid sodium oleate and the cholinergic agonist bethanechol were also found to stimulate IR-PYY secretion, each at a concentration of 10(-4) M (P less than 0.001). The results of the present study indicate that the synthesis and secretion of PYY by the rat intestine is under the regulatory control of a wide variety of extracellular agents, mediated by several intracellular signalling pathways.
Enteroendocrine cell-derived peptide YY signalling is stimulated by pinolenic acid or Intralipid and involves coactivation of fatty acid receptors FFA1, FFA4 and GPR119

Iain R. Tough,Runisha Moodaley,Helen M. Cox

DOI: https://doi.org/10.1016/j.npep.2024.102477

IF: 3.152

2024-10-12

Neuropeptides

Abstract:Long chain fatty acids are sensed by enteroendocrine L cells that express free-fatty acid receptors, including FFA1, FFA4 and the acylethanolamine receptor GPR119. Here we investigated the acute effects of single or multiple agonism at these G protein-coupled receptors in intestinal mucosae where L cell-derived peptide YY (PYY) is anti-secretory and acts via epithelial Y 1 receptors. Mouse ileal or colonic mucosae were mounted in Ussing chambers, voltage-clamped and the resultant short-circuit current (I sc ) recorded continuously. The agonists used were; FFA1, TAK-875 or AM-1638; for FFA4, Merck A; or for GPR119, AR231453, PSN632408 or AR440006. Their responses were compared with those of pinolenic acid (PA, a presumed dual FFA1/FFA4 agonist) and the lipid emulsion, Intralipid. The FFA1 agonist AM-1638 (EC 50 = 38.2 nM) was more potent than TAK-875 (EC 50 = 203.1 nM) but exhibited similar efficacy. GPR119 agonism (AR231453) pretreatment enhanced subsequent FFA1 (AM-1638 or TAK-875) and FFA4 (Merck A) signalling. PA (EC 50 = 298.2 nM) co-activated epithelial FFA1 and FFA4 and involved endogenous PYY Y 1 /Y 2 -receptor mechanisms but desensitisation was observed between PA and high GPR119 agonist concentrations. Apical Intralipid co-activated FFA1, FFA4 and GPR119 with a residual component not being attributable to PYY, or this trio of fatty acid receptors.

neurosciences,endocrinology & metabolism
Pathological-changes of the blood-cells in griseofulvin treated toads.

M. Elmofty,N. Abdelmeguid,A. Essawy

DOI: https://doi.org/10.3892/OR.2.1.167

Abstract:Griseofulvin is a valuable oral antifungal drug, used extensively in the treatment of superficial fungal infections of man and animals. Electron microscopical studies of peripheral blood of toads force-fed with griseofulvin revealed pronounced alterations of the blood cells more or less similar to the criteria of monocytic leukaemia and were all comparable to those observed after the administration of the carcinogenic chemical 7,12 dimethylbenz(a)anthracene.
Effect of various zinc oxide materials as root-end fillings on healing after replantation.

T. Pitt Ford,J. Andreasen,S. Dorn,S. Kariyawasam

DOI: https://doi.org/10.1111/J.1365-2591.1995.TB00315.X

1995-11-01

International Endodontic Journal

Abstract:This study examined the effect of various zinc oxide materials as root-end fillings of teeth in a replantation model. A total of 35 molar teeth were used from 19 monkeys. After extraction, root ends were resected, the canals contaminated with oral bacteria, root-end cavities prepared and fillings placed prior to replantation. After 8 weeks the teeth and surrounding jaw were removed and prepared for histological examination. Twelve roots were filled with IRM plus dentine chips, and six with Cavit; the tissue response around root ends filled with these materials as assessed by inflammation was similar to that previous reported to IRM and Super EBA cement and was characterized by little or no inflammation of limited extent. In contrast, more severe inflammation was observed around root ends filled with plain zinc oxide-eugenol or Kalzinol; however, the reaction was neither as severe nor as extensive as that to amalgam root-end fillings. Giant cells were observed most often on the surface of fillings with Cavit and zinc oxide-eugenol. It is concluded that the tissue response to IRM with or without added dentine, Super EBA and Cavit was similar and mild; it was less severe than that to zinc oxide-eugenol and Kalzinol. All these materials had a much more favourable response than amalgam
Peptide YY, appetite and food intake

C W le Roux,S R Bloom

DOI: https://doi.org/10.1079/pns2005427

Abstract:Obesity is taking on pandemic proportions. The laws of thermodynamics, however, remain unchanged, as energy will be stored if less energy is expended than consumed; the storage is usually in the form of adipose tissue. Several neural, humeral and psychological factors control the complex process known as appetite. Recently, a close evolutionary relationship between the gut and brain has become apparent. The gut hormones regulate important gastrointestinal functions such as motility, secretion, absorption, provide feedback to the central nervous system on availability of nutrients and may play a part in regulating food intake. Peptide YY (PYY) is a thirty-six amino acid peptide related to neuropeptide Y (NPY) and is co-secreted with glucagon-like peptide 1. Produced by the intestinal L-cells, the highest tissue concentrations of PYY are found in distal segments of the gastrointestinal tract, although it is present throughout the gut. Following food intake PYY is released into the circulation. PYY concentrations are proportional to meal energy content and peak plasma levels appear postprandially after 1 h. PYY3-36 is a major form of PYY in both the gut mucosal endocrine cells and the circulation. Peripheral administration of PYY3-36 inhibits food intake for several hours in both rodents and man. The binding of PYY3-36 to the Y2 receptor leads to an inhibition of the NPY neurones and a possible reciprocal stimulation of the pro-opiomelanocortin neurones. Thus, PYY3-36 appears to control food intake by providing a powerful feedback on the hypothalamic circuits. The effect on food intake has been demonstrated at physiological concentrations and, therefore, PYY3-36 may be important in the everyday regulation of food intake.
Antimicrobial susceptibility of Clostridium difficile isolates from ICU colonized patients revealed alert to ST-37 (RT 017) isolates.

Jingyu Yang,Xiaoxia Zhang,Xiaohua Liu,Lin Cai,Ping Feng,Xiaohui Wang,Z. Zong

DOI: https://doi.org/10.1016/j.diagmicrobio.2017.06.021

IF: 2.983

2017-10-01

Diagnostic Microbiology and Infectious Disease

Abstract:
Agonism of free fatty acid receptors 1 and 4 generates peptide YY-mediated inhibitory responses in mouse colon

Runisha Moodaley,David M Smith,Iain R Tough,Marcus Schindler,Helen M Cox

DOI: https://doi.org/10.1111/bph.14054

Abstract:Background and purpose: Free fatty acid receptors FFA1 and FFA4 are located on enteroendocrine L cells with the highest gastrointestinal (GI) expression in descending colon. Their activation causes the release of glucagon-like peptide 1 and peptide YY (PYY) from L cells. Additionally, FFA1 agonism releases insulin from pancreatic β cells. As these receptors are modulators of nutrient-stimulated glucose regulation, the aim of this study was to compare the pharmacology of commercially available agonists (TUG424, TUG891, GW9508) with proven selective agonists (JTT, TAK-875, AZ423, Metabolex-36) in mice. Experimental approach: Mouse mucosa was mounted in Ussing chambers, voltage-clamped and the resultant short-circuit current (Isc ) was recorded continuously. Pretreatments included antagonists of FFA1, Y1 or Y2 receptors. Glucose sensitivity was investigated by mannitol replacement apically, and colonic and upper GI transit was assessed in vitro and in vivo. Key results: FFA1 and FFA4 agonism required glucose and reduced Isc in a PYY-Y1 receptor-dependent manner. The novel compounds were more potent than GW9508. The FFA1 antagonists (GW1100 and ANT825) blocked FFA1 activity only and revealed FFA1 tonic activity. The FFA4 agonist, Metabolex-36, slowed colonic transit in vitro but increased small intestinal transit in vivo. Conclusions and implications: The selective FFA1 and FFA4 agonists were more potent at reducing Isc than GW9508, a dual FFA1 and FFA4 agonist. A paracrine epithelial mechanism involving PYY-stimulated Y1 receptors mediated their responses, which were glucose sensitive, potentially limiting hypoglycaemia. ANT825 revealed tonic activity and the possibility of endogenous FFA1 ligands causing PYY release. Finally, FFA4 agonism induced regional differences in transit.
Short chain fatty acids stimulate insulin secretion and reduce apoptosis in mouse and human islets in vitro: Role of free fatty acid receptor 2

Attilio Pingitore,Noemi Gonzalez‐Abuin,Inmaculada Ruz‐Maldonado,Guo C. Huang,Gary Frost,Shanta J. Persaud,Noemi Gonzalez-Abuin,Inmaculada Ruz-Maldonado

DOI: https://doi.org/10.1111/dom.13529

2018-10-03

Diabetes, Obesity and Metabolism

Abstract:AIMS: To evaluate the role of free fatty acid receptor 2 (FFAR2)/G-protein coupled receptor 43 in mediating the effects of the short chain fatty acids (SCFAs) sodium acetate (SA) and sodium propionate (SP) on islet function in vitro, and to identify the intracellular signalling pathways used in SCFA-induced potentiation of glucose-induced insulin secretion.MATERIALS AND METHODS: Islets of Langerhans were isolated from wild-type and FFAR2-/- mice and from human donors without diabetes. The effects of SA and SP on dynamic insulin secretion from perifused islets were quantified by radioimmunoassay, signalling downstream of SCFAs was profiled by single-cell calcium microfluorimetry, and measurement of cAMP was performed using a fluorescence assay. Islet apoptosis was induced by exposure to cytokines or sodium palmitate, and the effects of SA and SP in regulating islet apoptosis were assessed by quantification of caspase 3/7 activities.RESULTS: Deletion of FFAR2 did not affect islet morphology or insulin content. SA and SP reversibly potentiated insulin secretion from mouse islets in a FFAR2-dependent manner. SCFA-induced potentiation of insulin secretion was coupled to Gq activation of phospholipase C and protein kinase C, with no evidence of Gi-mediated signalling. SA and SP protected human and mouse islets from apoptosis, and these pro-survival properties were dependent on islet expression of FFAR2.CONCLUSION: Our results indicate that FFAR2 directly mediates both the stimulatory effects of SA and SP on insulin secretion and their protection against islet apoptosis. We have also shown that SCFA coupling in islets occurs via Gq-coupled intracellular signalling.
Gut microbial short-chain fatty acids-mediated olfactory receptor 78 stimulation promotes anorexigenic gut hormone peptide YY secretion in mice

Akari Nishida,Junki Miyamoto,Hidenori Shimizu,Ikuo Kimura

DOI: https://doi.org/10.1016/j.bbrc.2021.03.167

2021-06-11

Abstract:Olfactory receptor 78 (Olfr78), which is also known as a receptor for short-chain fatty acids (SCFAs) produced via gut microbial fermentation from indigestible polysaccharides such as dietary fibers, is expressed in the enteroendocrine cells of the colon. However, the role of Olfr78 in gut hormone secretion remains unknown. Here, we aimed to investigate the function and mechanism of action of Olfr78 in vivo and in vitro. Toward this, we assessed the expression of Olfr78 in several tissues, affinity of Olfr78 to various monocarboxylates, and the secretion of anorexigenic gut hormone peptide YY (PYY) via Olfr78 using various molecular and biochemical techniques. Olfr78 was abundantly expressed in the colon and mouse enteroendocrine cell line STC-1 and showed specific affinity to SCFAs such as acetate and propionate, but not butyrate, in a monocarboxylate ligand screening assay using a heterologous expression system. Acetate promoted PYY secretion in STC-1 cells via Olfr78-protein kinase A signaling, whereas the effects were abolished by Olfr78 RNA interference. Colonic SCFAs production via oral administration of fructo-oligosaccharide significantly increased plasma PYY levels, whereas this effect was abolished in Olfr78-deficient and germ-free mice. These results suggested that the SCFA receptor Olfr78 is important for anti-obesity and anorexigenic effects of the gut microbiota and dietary fibers.
Short chain fatty acids could prevent fat deposition in pigs via regulating related hormones and genes.

Jun He,Yuheng Luo,Jie Yu,P. Zheng,X. Mao,Junqiu Luo,A. Jiao,B. Yu,Daiwen Chen

DOI: https://doi.org/10.1039/c9fo02585e

IF: 6.3173

2020-02-18

Food & Function

Abstract:Short chain fatty acids (SCFAs) are produced when indigestible carbohydrates, such as fiber and resistant starch, undergo fermentation by specific microbiota in the hindgut. This study was designed to investigate the effects of different SCFAs on the glucolipid metabolism and appetite regulation of pigs. In a 28-day experiment, 30 barrows were divided into five groups: (1) control, (2) 0.1% sodium acetate, (3) 0.1% sodium propionate, (4) 0.1% sodium butyrate, and (5) 0.1% mixed sodium SCFAs (in the ratio of 3 : 1 : 1, respectively). Acetate administration reduced the average daily feed intake and average daily body weight gain of pigs (P < 0.05), decreased serum triglyceride (TG), total cholesterol (TC) and low density lipoprotein-cholesterol (LDL-c) concentrations (P < 0.05), increased serum glucagon-like peptide 1 (GLP-1), peptide YY (PYY) and leptin concentrations (P < 0.05), down-regulated fatty acid synthase (FAS), acetyl-CoA carboxylase (ACC) and sterol regulatory element binding protein 1c (SREBP-1c) mRNA expressions in the liver (P < 0.05), enhanced silent information regulator1 (SIRT1) mRNA expression in the longissimus dorsi (P < 0.05), and up-regulated free fatty acids receptor 2 (FFAR2) and PYY mRNA expressions in the colon (P < 0.05). Propionate administration also decreased serum TG, TC, and LDL-c concentrations (P < 0.05), increased serum GLP-1, PYY and leptin concentrations (P < 0.05), down-regulated glucose-6-phosphatase (G6PC) mRNA expression in the liver (P < 0.05), enhanced PPARγ coactivator-1α (PGC-1α) mRNA expression in the liver (P < 0.05), stimulated SIRT1 mRNA expression in the longissimus dorsi (P < 0.05), and up-regulated G6PC and glucagon mRNA expressions in the colon (P < 0.05). Butyrate administration down-regulated G6PC mRNA expression in the liver (P < 0.05), enhanced PGC-1α mRNA expression in the liver (P < 0.05), and increased lipase hormone-sensitive (LIPE) and carnitine palmitoyltransferase-1α (CPT-1α) mRNA expressions in the longissimus dorsi (P < 0.05). Overall, these results suggested that SCFAs could reduce lipogenesis, and enhance lipolysis in different tissues of pigs via regulating related hormones and genes, which would further illustrate the mechanisms underlying the beneficial effects of SCFAs on appetite and body weight control.

Agricultural and Food Sciences,Chemistry,Medicine
Butyrate and Propionate Protect against Diet-Induced Obesity and Regulate Gut Hormones via Free Fatty Acid Receptor 3-Independent Mechanisms

Hua V. Lin,Andrea Frassetto,Edward J. Kowalik,Andrea R. Nawrocki,Mofei M. Lu,Jennifer R. Kosinski,James A. Hubert,Daphne Szeto,Xiaorui Yao,Gail Forrest,Donald J. Marsh,Edward J. Kowalik Jr

DOI: https://doi.org/10.1371/journal.pone.0035240

IF: 3.7

2012-04-10

PLoS ONE

Abstract:Short-chain fatty acids (SCFAs), primarily acetate, propionate, and butyrate, are metabolites formed by gut microbiota from complex dietary carbohydrates. Butyrate and acetate were reported to protect against diet-induced obesity without causing hypophagia, while propionate was shown to reduce food intake. However, the underlying mechanisms for these effects are unclear. It was suggested that SCFAs may regulate gut hormones via their endogenous receptors Free fatty acid receptors 2 (FFAR2) and 3 (FFAR3), but direct evidence is lacking. We examined the effects of SCFA administration in mice, and show that butyrate, propionate, and acetate all protected against diet-induced obesity and insulin resistance. Butyrate and propionate, but not acetate, induce gut hormones and reduce food intake. As FFAR3 is the common receptor activated by butyrate and propionate, we examined these effects in FFAR3-deficient mice. The effects of butyrate and propionate on body weight and food intake are independent of FFAR3. In addition, FFAR3 plays a minor role in butyrate stimulation of Glucagon-like peptide-1, and is not required for butyrate- and propionate-dependent induction of Glucose-dependent insulinotropic peptide. Finally, FFAR3-deficient mice show normal body weight and glucose homeostasis. Stimulation of gut hormones and food intake inhibition by butyrate and propionate may represent a novel mechanism by which gut microbiota regulates host metabolism. These effects are largely intact in FFAR3-deficient mice, indicating additional mediators are required for these beneficial effects.

multidisciplinary sciences
Short-chain Fatty Acids can Improve Lipid and Glucose Metabolism Independently of the Gut Microbiota

Hua Zhou,Bing Yu,Jing Sun,Zuohua Liu,Hong Chen,Liangpeng Ge,Daiwen Chen

DOI: https://doi.org/10.21203/rs.3.rs-102479/v1

2020-11-09

Abstract:Abstract Background: Previous research has shown that exogenously short-chain fatty acids (SCFAs) infusion attenuated the body fat deposition in both mice, humans, and pigs. However, limited studies have evaluated the effects of SCFAs on lipid and glucose metabolism independently of the gut microbiota. Therefore, the present study was conducted to investigate the effects of exogenous infusion of SCFAs on lipid and glucose metabolism in a germ-free (GF) pig model. Methods: Twelve hysterectomy-derived newborn pigs were reared in six sterile isolators. All pigs were hand-fed Co60-γ-irradiated sterile milk powder for 21 days and switched from liquid to sterile solid feed for another 21 days. In the second 21-days period, GF pigs (n = 6) were orally infused with 25 mL/kg sterile saline per day, FA pigs (n = 6) were orally infused with 25 mL/kg SCFAs mixture (acetic, propionic, and butyric acids, 45, 15, and 11 mM, respectively) per day. Results: Orally infused with SCFAs tended to increase the concentration of adiponectin in serum, the activity of CPT-1 in longissimus dorsi, and the ANGPTL4 mRNA expression in colon ( P < 0.10). Meanwhile, the mRNA abundances of ACC, FAS, and SREBP-1C in liver and CD36 in longissimus dorsi were decreased ( P < 0.05), and the concentrations of ATP, ADP, or AMP in liver and longissimus dorsi were reduced ( P < 0.05) in FA group. Besides, the mRNA expressions of PGC-1α in liver and LPL in longissimus dorsi were tended to ( P < 0.10) increase and downregulate in FA group respectively. Moreover, the protein level of GPR43 was tended to increase ( P < 0.10), and ACC was tended to decrease ( P < 0.10), while the p-AMPK/T-AMPK ratio ( P < 0.05) was upregulated in liver of FA group. Also, oral administration of SCFAs upregulated the mRNA expressions of SLC2a and GYS2 in liver ( P < 0.05). Furthermore, the metabolic pathway associated with the biosynthesis of unsaturated fatty acids was significantly promoted ( P < 0.05) by orally infused with SCFAs. Conclusions: Short-chain fatty acids could attenuate fat deposition and to some extent improve glucose control, and were occur independently of the gut microbiota.
Change of hepatic arterial systolic/diastolic ratio predicts ischemic type biliary lesion after orthotropic liver transplantation.

Haiming Zhang,Yuexian Shi,Hong-tao Wu,Guang Chen,Ying Tang,Lei Liu,Zhi-jun Zhu

DOI: https://doi.org/10.1016/j.clinimag.2016.01.013

IF: 2.42

2016-05-01

Clinical Imaging

Abstract:
The vagus nerve mediates the physiological but not pharmacological effects of PYY3-36 on food intake

Aldara Martin Alonso,Simon C. Cork,Phyllis Phuah,Benjamin Hansen,Mariana Norton,Sijing Cheng,Xiang Xu,Kinga Suba,Yue Ma,Georgina KC. Dowsett,John A. Tadross,Brian YH. Lam,Giles SH. Yeo,Herbert Herzog,Stephen R. Bloom,Myrtha Arnold,Walter Distaso,Kevin G. Murphy,Victoria Salem

DOI: https://doi.org/10.1016/j.molmet.2024.101895

IF: 8.568

2024-03-01

Molecular Metabolism

Abstract:Peptide YY (PYY3-36) is a post-prandially released gut hormone with potent appetite-reducing activity, the mechanism of action of which is not fully understood. Unravelling how this system physiologically regulates food intake may help unlock its therapeutic potential, whilst minimising unwanted effects. Here we demonstrate that germline and post-natal targeted knockdown of the PYY3-36 preferring receptor (neuropeptide Y (NPY) Y2 receptor (Y2R)) in the afferent vagus nerve is required for the appetite inhibitory effects of physiologically-released PYY3-36, but not peripherally administered pharmacological doses. Post-natal knockdown of the Y2R results in a transient body weight phenotype that is not evident in the germline model. Loss of vagal Y2R signalling also results in altered meal patterning associated with accelerated gastric emptying. These results are important for the design of PYY-based anti-obesity agents.

endocrinology & metabolism
Controversial Roles of Gut Microbiota-Derived Short-Chain Fatty Acids (SCFAs) on Pancreatic β-Cell Growth and Insulin Secretion

Jun-Li Liu,Irina Segovia,Xiao-Lin Yuan,Zu-hua Gao

DOI: https://doi.org/10.3390/ijms21030910

IF: 5.6

2020-01-30

International Journal of Molecular Sciences

Abstract:In the past 15 years, gut microbiota emerged as a crucial player in health and disease. Enormous progress was made in the analysis of its composition, even in the discovery of novel species. It is time to go beyond mere microbiota-disease associations and, instead, provide more causal analyses. A key mechanism of metabolic regulation by the gut microbiota is through the production of short-chain fatty acids (SCFAs). Acting as supplemental nutrients and specific ligands of two G-protein-coupled receptors (GPCRs), they target the intestines, brain, liver, and adipose tissue, and they regulate appetite, energy expenditure, adiposity, and glucose production. With accumulating but sometimes conflicting research results, key questions emerged. Do SCFAs regulate pancreatic islets directly? What is the effect of β-cell-specific receptor deletions? What are the mechanisms used by SCFAs to regulate β-cell proliferation, survival, and secretion? The receptors FFA2/3 are normally expressed on pancreatic β-cells. Deficiency in FFA2 may have caused glucose intolerance and β-cell deficiency in mice. However, this was contrasted by a double-receptor knockout. Even more controversial are the effects of SCFAs on insulin secretion; there might be no direct effect at all. Unable to draw clear conclusions, this review reveals some of the recent controversies.

biochemistry & molecular biology,chemistry, multidisciplinary
Short-chain fatty acids can improve lipid and glucose metabolism independently of the pig gut microbiota

Hua Zhou,Bing Yu,Jing Sun,Zuohua Liu,Hong Chen,Liangpeng Ge,Daiwen Chen

DOI: https://doi.org/10.1186/s40104-021-00581-3

2021-05-06

Journal of Animal Science and Biotechnology

Abstract:Abstract Background Previous studies have shown that exogenous short-chain fatty acids (SCFAs) introduction attenuated the body fat deposition in conventional mice and pigs. However, limited studies have evaluated the effects of exogenously introduced SCFAs on the lipid and glucose metabolism independently of the gut microbiota. This study was to investigate the effects of exogenous introduction of SCFAs on the lipid and glucose metabolism in a germ-free (GF) pig model. Methods Twelve hysterectomy-derived newborn pigs were reared in six sterile isolators. All pigs were hand-fed with sterile milk powder for 21 d, then the sterile feed was introduced to pigs for another 21 d. In the second 21-d period, six pigs were orally administrated with 25 mL/kg sterile saline per day and considered as the GF group, while the other six pigs were orally administrated with 25 mL/kg SCFAs mixture (acetic, propionic, and butyric acids, 45, 15, and 11 mmol/L, respectively) per day and regarded as FA group. Results Orally administrated with SCFAs tended to increase the adiponectin concentration in serum, enhance the CPT-1 activity in longissimus dorsi, and upregulate the ANGPTL4 mRNA expression level in colon ( P < 0.10). Meanwhile, the mRNA abundances of ACC , FAS , and SREBP-1C in liver and CD36 in longissimus dorsi of the FA group were decreased ( P < 0.05) compared with those in the GF group. Besides, the mRNA expression of PGC-1α in liver and LPL in longissimus dorsi tended to ( P < 0.10) upregulate and downregulate respectively in the FA group. Moreover, oral administration of SCFAs tended to increase the protein level of GPR43 ( P < 0.10) and decrease the protein level of ACC ( P < 0.10) in liver. Also, oral administration of SCFAs upregulated the p-AMPK/AMPK ratio and the mRNA expressions of GLUT-2 and GYS2 in liver ( P < 0.05). In addition, the metabolic pathway associated with the biosynthesis of unsaturated fatty acids was most significantly promoted ( P < 0.05) by oral administration of SCFAs. Conclusions Exogenous introduction of SCFAs might attenuate the fat deposition and to some extent improve the glucose control in the pig model, which occurred independently of the gut microbiota.

agriculture, dairy & animal science
Diet shapes the metabolite profile in the intact human ileum, which affects PYY release

Aygul Dagbasi,Claire Byrne,Dominic Blunt,Jose Ivan Serrano-Contreras,Georgia Franco Becker,Jesus Miguens Blanco,Stephane Camuzeaux,Edward Chambers,Nathan Danckert,Cathrina Edwards,Andres Bernal,Maria Valdivia Garcia,Aylin Hanyaloglu,Elaine Holmes,Yue Ma,Julian Marchesi,Laura Martinez-Gili,Lilian Mendoza,Martina Tashkova,Natalia Perez-Moral,Isabel Garcia-Perez,Andres Castillo Robles,Caroline Sands,Julien Wist,Kevin G. Murphy,Gary Frost

DOI: https://doi.org/10.1126/scitranslmed.adm8132

IF: 17.1

2024-06-20

Science Translational Medicine

Abstract:The human ileum contains a high density of enteroendocrine L-cells, which release the appetite-suppressing hormones glucagon-like peptide-1 (GLP-1) and peptide tyrosine tyrosine (PYY) in response to food intake. Recent evidence highlighted the potential role of food structures in PYY release, but the link between food structures, ileal metabolites, and appetite hormone release remains unclear owing to limited access to intact human ileum. In a randomized crossover trial (ISRCTN11327221; isrctn.com ), we investigated the role of human ileum in GLP-1 and PYY release by giving healthy volunteers diets differing in fiber and food structure: high-fiber (intact or disrupted food structures) or low-fiber disrupted food structures. We used nasoenteric tubes to sample chyme from the intact distal ileum lumina of humans in the fasted state and every 60 min for 480 min postprandially. We demonstrate the highly dynamic, wide-ranging molecular environment of the ileum over time, with a substantial decrease in ileum bacterial numbers and bacterial metabolites after food intake. We also show that high-fiber diets, independent of food structure, increased PYY release compared with a low-fiber diet during 0 to 240 min postprandially. High-fiber diets also increased ileal stachyose, and a disrupted high-fiber diet increased certain ileal amino acids. Treatment of human ileal organoids with ileal fluids or an amino acid and stachyose mixture stimulated PYY expression in a similar profile to blood PYY concentrations, confirming the role of ileal metabolites in PYY release. Our study demonstrates the diet-induced changes over time in the metabolite environment of intact human ileum, which play a role in PYY release.

cell biology,medicine, research & experimental

Study on the bias-dependent effects of proton-induced damage in CdZnTe radiation detectors using ion beam induced charge microscopy.

Short-Chain Fatty Acids Stimulate Glucagon-Like Peptide-1 Secretion via the G-Protein–Coupled Receptor FFAR2

Food and feeding habit of taiwan mauxia shrimp Acetes intermedius in the coastal waters of Southwestern Taiwan

[THE AIR TRAVELER WITH RESPECT TO THE HYGIENIST].

Regulation of peptide-YY synthesis and secretion in fetal rat intestinal cultures

Enteroendocrine cell-derived peptide YY signalling is stimulated by pinolenic acid or Intralipid and involves coactivation of fatty acid receptors FFA1, FFA4 and GPR119

Pathological-changes of the blood-cells in griseofulvin treated toads.

Effect of various zinc oxide materials as root-end fillings on healing after replantation.

Peptide YY, appetite and food intake

Antimicrobial susceptibility of Clostridium difficile isolates from ICU colonized patients revealed alert to ST-37 (RT 017) isolates.

Agonism of free fatty acid receptors 1 and 4 generates peptide YY-mediated inhibitory responses in mouse colon

Short chain fatty acids stimulate insulin secretion and reduce apoptosis in mouse and human islets in vitro: Role of free fatty acid receptor 2

Gut microbial short-chain fatty acids-mediated olfactory receptor 78 stimulation promotes anorexigenic gut hormone peptide YY secretion in mice

Short chain fatty acids could prevent fat deposition in pigs via regulating related hormones and genes.

Butyrate and Propionate Protect against Diet-Induced Obesity and Regulate Gut Hormones via Free Fatty Acid Receptor 3-Independent Mechanisms

Short-chain Fatty Acids can Improve Lipid and Glucose Metabolism Independently of the Gut Microbiota

Change of hepatic arterial systolic/diastolic ratio predicts ischemic type biliary lesion after orthotropic liver transplantation.

The vagus nerve mediates the physiological but not pharmacological effects of PYY3-36 on food intake

Controversial Roles of Gut Microbiota-Derived Short-Chain Fatty Acids (SCFAs) on Pancreatic β-Cell Growth and Insulin Secretion

Short-chain fatty acids can improve lipid and glucose metabolism independently of the pig gut microbiota

Diet shapes the metabolite profile in the intact human ileum, which affects PYY release